The Current State of Treatment Implementation for Metastatic Hormone Sensitive Prostate Cancer in North America
prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), androgen deprivation therapy (ADT), apalutamide, enzalutamide, Current State of Treatment Implementation for Metastatic Hormone Sensitive Prostate Cancer, docetaxel, LATITUDE trial, STAMPEDE trial, GETUG-15 trial, CHAARTED trial, ENZAMET trial, Synchronous Low Volume mHSPC, Synchronous High Volume mHSPC, ARASENS trial, SWOG 1802 trial, TITAN trial, PEACE-1 trial, ARCHES trial, Primary Radiotherapy for synchronous, low volume mHSPC patients, Metachronous Low Volume mHSPC, HORRAD trial, GETUG-AFU15, Metachronous High Volume mHSPC.